<VariationArchive VariationID="433931" VariationName="NM_000179.3(MSH6):c.3957dup (p.Ala1320fs)" VariationType="Duplication" Accession="VCV000433931" Version="9" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-06-23" DateCreated="2017-08-28" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="427192" VariationID="433931">
      <GeneList>
        <Gene Symbol="MSH6" FullName="mutS homolog 6" GeneID="2956" HGNC_ID="HGNC:7329" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2p16.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="47783145" stop="47810101" display_start="47783145" display_stop="47810101" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="48010220" stop="48034091" display_start="48010220" display_stop="48034091" Strand="+" />
          </Location>
          <OMIM>600678</OMIM>
          <Haploinsufficiency last_evaluated="2021-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MSH6">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MSH6">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000179.3(MSH6):c.3957dup (p.Ala1320fs)</Name>
      <CanonicalSPDI>NC_000002.12:47806603:AAAA:AAAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2p16.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="47806603" stop="47806604" display_start="47806603" display_stop="47806604" variantLength="1" positionVCF="47806603" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="48033742" stop="48033743" display_start="48033742" display_stop="48033743" variantLength="1" positionVCF="48033742" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
      </Location>
      <ProteinChange>A1018fs</ProteinChange>
      <ProteinChange>A1190fs</ProteinChange>
      <ProteinChange>A1320fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000179.2" sequenceAccession="NM_000179" sequenceVersion="2" change="c.3957dupA">
            <Expression>NM_000179.2:c.3957dupA</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.48033746dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.48033746dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.47806607dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.47806607dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007111.1" sequenceAccession="NG_007111" sequenceVersion="1" change="g.28461dup">
            <Expression>NG_007111.1:g.28461dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008397.1" sequenceAccession="NG_008397" sequenceVersion="1" change="g.104072dup">
            <Expression>NG_008397.1:g.104072dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000179.3" sequenceAccession="NM_000179" sequenceVersion="3" change="c.3957dup" MANESelect="true">
            <Expression>NM_000179.3:c.3957dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000170.1" sequenceAccession="NP_000170" sequenceVersion="1" change="p.Ala1320fs">
            <Expression>NP_000170.1:p.Ala1320fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001281492.2" sequenceAccession="NM_001281492" sequenceVersion="2" change="c.3567dup">
            <Expression>NM_001281492.2:c.3567dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001268421.1" sequenceAccession="NP_001268421" sequenceVersion="1" change="p.Ala1190fs">
            <Expression>NP_001268421.1:p.Ala1190fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001281493.2" sequenceAccession="NM_001281493" sequenceVersion="2" change="c.3051dup">
            <Expression>NM_001281493.2:c.3051dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001268422.1" sequenceAccession="NP_001268422" sequenceVersion="1" change="p.Ala1018fs">
            <Expression>NP_001268422.1:p.Ala1018fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001281494.2" sequenceAccession="NM_001281494" sequenceVersion="2" change="c.3051dup">
            <Expression>NM_001281494.2:c.3051dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001268423.1" sequenceAccession="NP_001268423" sequenceVersion="1" change="p.Ala1018fs">
            <Expression>NP_001268423.1:p.Ala1018fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_219" sequenceAccession="LRG_219">
            <Expression>LRG_219:g.28461dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA072375" DB="ClinGen" />
        <XRef Type="rs" ID="587779297" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000179.3(MSH6):c.3957dup (p.Ala1320fs) AND Carcinoma of colon" Accession="RCV000503361" Version="3">
        <ClassifiedConditionList TraitSetID="1735">
          <ClassifiedCondition DB="MedGen" ID="C0699790">Carcinoma of colon</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000179.3(MSH6):c.3957dup (p.Ala1320fs) AND Hereditary cancer-predisposing syndrome" Accession="RCV003278849" Version="2">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-06" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000179.3(MSH6):c.3957dup (p.Ala1320fs) AND Lynch syndrome 5" Accession="RCV003449414" Version="1">
        <ClassifiedConditionList TraitSetID="2460">
          <ClassifiedCondition DB="MedGen" ID="C1833477">Lynch syndrome 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000179.3(MSH6):c.3957dup (p.Ala1320fs) AND Endometrial carcinoma" Accession="RCV003464073" Version="1">
        <ClassifiedConditionList TraitSetID="1474">
          <ClassifiedCondition DB="MedGen" ID="C0476089">Endometrial carcinoma</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-06-11" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000179.3(MSH6):c.3957dup (p.Ala1320fs) AND Hereditary nonpolyposis colorectal neoplasms" Accession="RCV002524137" Version="2">
        <ClassifiedConditionList TraitSetID="37727">
          <ClassifiedCondition DB="MedGen" ID="C0009405">Hereditary nonpolyposis colorectal neoplasms</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-02-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-28" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2017-08-28" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18809606</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19459153</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21155762</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25186627</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25980754</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26552419</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26681312</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26845104</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27456091</ID>
        </Citation>
        <DescriptionHistory Dated="2023-07-08">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="1474" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1151" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Endometrial carcinoma</ElementValue>
                <XRef ID="Endometrial+cancer/8312" DB="Genetic Alliance" />
                <XRef ID="HP:0012114" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0002447" DB="MONDO" />
                <XRef ID="254878006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Endometrial carcinoma, somatic</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="AHRQ, 2013">
                <URL>https://www.cms.gov/Medicare/Coverage/DeterminationProcess/downloads/id90TA.pdf</URL>
                <CitationText>Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin (ARCHIVED)</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="SGO, 2014">
                <ID Source="PubMed">24905773</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2014">
                <ID Source="PubMed">24493721</ID>
              </Citation>
              <Citation Type="general" Abbrev="SGO, 2021">
                <ID Source="PubMed">33516529</ID>
              </Citation>
              <Citation Type="general" Abbrev="SGO, 2021">
                <ID Source="PubMed">33451724</ID>
              </Citation>
              <Citation Type="general" Abbrev="SGO, 2014">
                <ID Source="PubMed">24929052</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2020">
                <URL>https://www.nice.org.uk/guidance/dg42</URL>
                <CitationText>UK NICE Diagnostics Guidance DG42, Testing strategies for Lynch syndrome in people with endometrial cancer, 2020</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/uterine.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Uterine Neoplasms, 2024</CitationText>
              </Citation>
              <XRef ID="C0476089" DB="MedGen" />
              <XRef ID="MONDO:0002447" DB="MONDO" />
              <XRef Type="MIM" ID="608089" DB="OMIM" />
              <XRef Type="primary" ID="HP:0012114" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="37727" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="38245" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary nonpolyposis colorectal neoplasms</ElementValue>
                <XRef ID="D003123" DB="MeSH" />
              </Name>
              <XRef ID="C0009405" DB="MedGen" />
              <XRef ID="D003123" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1735" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="10229" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Colon carcinoma</ElementValue>
                <XRef ID="MONDO:0002032" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Carcinoma of colon</ElementValue>
                <XRef ID="269533000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Colonic carcinoma</ElementValue>
                <XRef ID="MONDO:0002032" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CRC</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Lynch syndrome is characterized by an increased risk for colorectal cancer (CRC) and cancers of the endometrium, ovary, stomach, small bowel, urinary tract, biliary tract, brain (usually glioblastoma), skin (sebaceous adenomas, sebaceous carcinomas, and keratoacanthomas), pancreas, and prostate. Cancer risks and age of onset vary depending on the associated gene. Several other cancer types have been reported to occur in individuals with Lynch syndrome (e.g., breast, sarcomas, adrenocortical carcinoma). However, the data are not sufficient to demonstrate that the risk of developing these cancers is increased in individuals with Lynch syndrome.</Attribute>
                <XRef ID="NBK1211" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301390</ID>
                <ID Source="BookShelf">NBK1211</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2009">
                <ID Source="pmc">2743612</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2009">
                <ID Source="pmc">2743610</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="AMA/NCHPEG, 2012">
                <URL>http://www.nchpeg.org/documents/crc/11-0456%20Fact%20sheets%20(MSI%20and%20IHC%20testing).pdf</URL>
              </Citation>
              <Citation Type="general" Abbrev="NACB, 2008">
                <ID Source="PubMed">19042984</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="AHRQ, 2013">
                <URL>https://www.cms.gov/Medicare/Coverage/DeterminationProcess/downloads/id90TA.pdf</URL>
                <CitationText>Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin (ARCHIVED)</CitationText>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Imperiale et al., 2014">
                <ID Source="PubMed">25006736</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2006">
                <ID Source="PubMed">17060676</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="NCCN, 2011">
                <ID Source="PubMed">22138009</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACP MPDG, 2014">
                <ID Source="PubMed">24996433</ID>
              </Citation>
              <Citation Type="general" Abbrev="SEAP/SEOM, 2012">
                <ID Source="PubMed">22855150</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESMO, 2012">
                <ID Source="PubMed">23012255</ID>
              </Citation>
              <Citation Type="general" Abbrev="SEAP/SEOM, 2015">
                <ID Source="PubMed">25373533</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGTM, 2014">
                <ID Source="PubMed">23852704</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2013">
                <ID Source="PubMed">23429431</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Colon Cancer, 2024</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="EHTG/ESCP, 2021">
                <ID Source="PubMed">34043773</ID>
              </Citation>
              <Citation Type="general" Abbrev="SEAP/SEOM, 2020">
                <ID Source="PubMed">32418154</ID>
                <ID Source="pmc">7505870</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Colon-Cancer.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Family History ACT Sheet, Colon Cancer (Asymptomatic), 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2021">
                <URL>https://www.nice.org.uk/guidance/ng151</URL>
                <CitationText>UK NICE Guideline NG151, Colorectal cancer, 2021</CitationText>
              </Citation>
              <XRef ID="C0699790" DB="MedGen" />
              <XRef ID="MONDO:0002032" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10492" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hereditary non-polyposis colorectal cancer, type 5</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Lynch syndrome 5</ElementValue>
                <XRef ID="MONDO:0013710" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Colorectal cancer, hereditary nonpolyposis, type 5</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LYNCH5</ElementValue>
                <XRef Type="MIM" ID="614350" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000501402" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515534" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507864" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000595970" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000502979" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569423" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528529" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530120" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512401" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501400" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520048" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520069" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000326160" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512492" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000510419" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569406" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512645" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000514730" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528914" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512403" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15792" />
                <XRef ID="15792" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="EHTG/ESCP, 2021">
                <ID Source="PubMed">34043773</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/PDFLibrary/Lynch-Syndrome.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, MLH1, MSH2, MSH6, PMS2, EPCAM Pathogenic Variants, Lynch Syndrome (Hereditary Non-polyposis Colon Cancer [HNPCC]), 2019</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2021">
                <URL>https://www.nice.org.uk/guidance/ng151</URL>
                <CitationText>UK NICE Guideline NG151, Colorectal cancer, 2021</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2020">
                <URL>https://www.nice.org.uk/guidance/dg42</URL>
                <CitationText>UK NICE Diagnostics Guidance DG42, Testing strategies for Lynch syndrome in people with endometrial cancer, 2020</CitationText>
              </Citation>
              <XRef ID="144" DB="Orphanet" />
              <XRef ID="C1833477" DB="MedGen" />
              <XRef ID="MONDO:0013710" DB="MONDO" />
              <XRef Type="MIM" ID="614350" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1149108" SubmissionDate="2021-03-31" DateLastUpdated="2021-04-13" DateCreated="2017-08-28">
        <ClinVarSubmissionID localKey="chr2:48033741-48033742:408fcbd1f57d3155ad7c35d1c97106fe-COLON" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000592664" DateUpdated="2021-04-13" DateCreated="2017-08-28" Type="SCV" Version="2" SubmitterName="Department of Pathology and Laboratory Medicine, Sinai Health System" OrgID="506152" OrganizationCategory="laboratory" OrgAbbreviation="PLM-SHS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506759" SubmitterName="Franklin by Genoox" Type="secondary" OrganizationCategory="other" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The p.Ala1320SerfsX5 variant was not identified in the literature. It was identified in one database, inSIGHT Colon Cancer database 1X as a pathogenic variant and associated with an MSI-H tumour. It was not identified in any of the following databases: dbSNP, 1000 Genomes Project, NHLBI Exome Sequencing Project (Exome Variant Server), Exome Aggregation Consortium (ExAC) database, HGMD, COSMIC, MutDB, â€šÃ„ÃºMismatch Repair Genes Variant Databaseâ€šÃ„Ã¹, â€šÃ„ÃºMMR Gene Unclassified Variants Databaseâ€šÃ„Ã¹, â€šÃ„ÃºZhejiang Colon Cancer Databaseâ€šÃ„Ã¹, the ClinVar database, GeneInsight VariantWire database, and UMD. The p.Ala1320SerfsX5 duplication variant is predicted to cause a frameshift, which alters the protein's amino acid sequence beginning at codon 1320 and leads to a premature stop codon 5 codons downstream. This alteration is then predicted to result in a truncated or absent protein and loss of function. Loss of function variants of the MSH6 gene are an established mechanism of disease in Lynch syndrome and this is the type of variant expected to cause the disorder. In summary, based on the above information, this variant meets our laboratoryâ€šÃ„Ã´s criteria to be classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MSH6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="GA" referenceAllele="G" start="48033742" stop="48033742" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0002032" />
          </Trait>
        </TraitSet>
        <StudyName>The Canadian Open Genetics Repository (COGR)</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB9371647</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7826840" SubmissionDate="2023-12-21" DateLastUpdated="2023-12-24" DateCreated="2023-12-24">
        <ClinVarSubmissionID localKey="100730331|OMIM:614350" />
        <ClinVarAccession Accession="SCV004187132" DateUpdated="2023-12-24" DateCreated="2023-12-24" Type="SCV" Version="1" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/8ufcwsf2/myriad_genetics_classification_criteria_2023.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MSH6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="2" alternateAllele="AA" referenceAllele="A" start="48033746" stop="48033746" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">100730331</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614350" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14104645</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7846570" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000179.3:c.3957dup|OMIM:608089" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004196372" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000179.3:c.3957dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="608089" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6011974" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="15947993|MedGen:C0009405" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003321867" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21155762</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18809606</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19459153</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25186627</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25980754</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26552419</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26681312</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26845104</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27456091</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the MSH6 protein in which other variant(s) (p.Ala1320Glufs*6) have been determined to be pathogenic (PMID: 21155762). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 433931). This premature translational stop signal has been observed in individual(s) with breast cancer, endometrial and ovarian cancer, and/or Lynch syndrome (PMID: 18809606, 19459153, 25186627, 25980754, 26552419, 26681312, 26845104, 27456091). This variant is present in population databases (rs587779297, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Ala1320Serfs*5) in the MSH6 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 41 amino acid(s) of the MSH6 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MSH6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.48033742_48033743insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0009405" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7426225" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2023-07-08">
        <ClinVarSubmissionID localKey="a8832319|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004007744" DateUpdated="2024-05-01" DateCreated="2023-07-08" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The c.3957dupA variant, located in coding exon 9 of the MSH6 gene, results from a duplication of A at nucleotide position 3957, causing a translational frameshift with a predicted alternate stop codon (p.A1320Sfs*5). This alteration occurs at the 3' terminus of theMSH6 gene, is not expected to trigger nonsense-mediated mRNA decay, and only impacts the last 41 amino acids of the protein. However, premature stop codons are typically deleterious in nature and the impacted region is critical for protein function (Ambry internal data). Based on the majority of available evidence to date, this variant is likely to be pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MSH6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000179.2:c.3957dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>FinalAVA3AVA4ClinvarDepositThrough061523</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7846570" TraitType="Disease" MappingType="XRef" MappingValue="608089" MappingRef="OMIM">
        <MedGen CUI="C0476089" Name="Endometrial carcinoma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7826840" TraitType="Disease" MappingType="XRef" MappingValue="614350" MappingRef="OMIM">
        <MedGen CUI="C1833477" Name="Lynch syndrome 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6011974" TraitType="Disease" MappingType="XRef" MappingValue="C0009405" MappingRef="MedGen">
        <MedGen CUI="C0009405" Name="Hereditary nonpolyposis colorectal neoplasms" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7426225" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1149108" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0002032" MappingRef="MONDO">
        <MedGen CUI="C0699790" Name="Carcinoma of colon" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

